Cognitive remediation in Recent Onset Schizophrenia: Results of an effectiveness trial
|
|
- Maryann Cobb
- 6 years ago
- Views:
Transcription
1 The Brain Dynamics Centre Westmead Hospital & University of Sydney Cognitive remediation in Recent Onset Schizophrenia: Results of an effectiveness trial Dr Anthony Harris University of Sydney & PEIRS, Sydney West Area Mental Health Service Funding This research was funded by the following bodies Eli Lilly Answers that Matter Perpetual Trustees Research Trust Fund of the Schizophrenia Fellowship of New South Wales
2 What are we treating when we treat schizophrenia? Positive Symptoms Negative Symptoms An old paradigm A more complex picture Positive Negative Excitement Cognitive Anxiety / Depression
3 Outcome determined overwhelmingly by two domains Positive Negative Excitement Cognitive Anxiety / Depression Dementia praecox there is an inevitable and progressive mental deterioration, the most striking feature of which are the patient s inexplicable lack of judgment and incoherence of thinking. And later: the premorbid level of mental ability is never fully recovered (Kraepelin, 1896)
4 Commonly described cognitive deficits in psychotic disorders Schizophrenia Bipolar Disorder Attention, concentration, & vigilance Memory Verbal memory Executive function Language skills Planning and executive function Major Depression Verbal memory Slowed mental speed Concentration deficits Severity of Cognitive Impairments in FEP Mean Z score Schizophrenia Affective Other Controls Current IQ Attn/vig Work Mem Verb Acq Verb Recall Vis Recall Visuospatial Cog Flex Verb Fluency Speed Fitzgerald et al, 2004 ANZJP 38,
5 WSFEP Project neuropsychological results Baseline 1-Year Follow-up Schiz T1 (n = 29) Affective T1 (n =11) Substance Induced T1 (n = 7) Schiz T2 (n = 29) Affective T2 (n = 11) Substance Induced T2 (n = 7) Current IQ Attn/Vig Work Mem Verb Acq Verb Recall Vis Recall Visuospatial Cog Flex Verb Fluency Speed Current IQ Attn/Vig Work Mem Verb Acq Verb Recall Vis Recall Visuospatial Cog Flex Verb Fluency Speed Relationship of cognitive function to psychosocial functioning Return to work influenced by negative symptoms & cognitive deficits Cognitive deficits appear to relate more directly to level of real life functioning than positive symptoms For FES, premorbid functioning, DUP, comorbid substance abuse also important
6 Can we treat cognitive deficits? Role of medication Older typical antipsychotics appear to do little to assist and may harm cognition Second Generation Antipsychotics (SGA) have all been shown to help cognitive problems Effect size of SGA on cognition = 0.20 (Twamley et al, 2003) Computer assisted Cognitive Remediation Use of set batteries of computer tasks from commercially available software Structured, standardised, based on learning principles Self paced High status, hopefully enjoyable Can be run in small groups Use feedback embedded in software Effect size = 0.43 (Twamley et al, 2003) (effect size of SGA on cognition = 0.20)
7 Commercial game and educational software
8 Who were our subjects? Diagnosis: Schizophrenia, schizophreniform or schizoaffective disorder Age: years No current substance abuse Evidence of a decrement in cognitive functioning Drawn from a range of early psychosis, community rehabilitation services and inpatient rehabilitation units Who were our therapists All clinicians project supported by area health Range of backgrounds including :- Nursing Occupational therapist Psychology masters and undergraduate degrees 1 week training Fortnightly supervision for first 6 months and then regular contact Log checked for treatment fidelity
9 What did our subjects do? Cognitive problems were assessed Familiarised with the computer (1-3 sessions) Attend treatment twice a week for weeks with centre s normal treating clinician 20 sessions defined as an adequate dose Worked at various computer games Therapist selects games on the basis of cognitive profile, guides, helps suggest ways of getting around problems, helps motivate Hypotheses That cognitive remediation would improve cognition over 20 session That improvements on scores would persist over a 15 week follow-up That subjects with a recent-onset disease (<2 yrs illness) would have a greater improvement compared with those with chronic illness Functional improvement would accompany cognitive improvement
10 Dropout n=14 n=36 Screen & Randomised n=69 n=33 Dropout n=12 Assess Assess Waitlist Control 15 weeks (n=25) Immediate Treatment 15 weeks (n=22) Assess Assess Treat 15 weeks (n=18) Dropout n=7 Dropout n=0 Follow-up 15 weeks (n=38) Assess Dropout n=2 Assess Cognitive Assessment Domain Attention Working Memory Delayed Verbal Recall Delay Visual Recall Cognitive Flexibility Executive Function Processing Speed Test Connors CPT omission WAIS digit span backwards RAVLT Delayed recall Delayed recall (Rey CF or Taylor CF) Tower Test DKEFS Sorting Test DKEFS Trail Making Test A
11 Subject characteristics Immediate Treat M:F = 21:15 Waitlist M:F = 20:13 mean SE mean SE Age CPZ equi PANSS PANSS PANSS gen Calgary DRS SOFAS Rosenberg SES Hypothesis 1: That cognitive remediation would improve cognition over 20 session
12 Results : Immediate Treatment vs Waitlist Domain Attention Working Memory Delayed Verbal Recall Delay Visual Recall Cognitive Flex. Executive Fx Processing Speed Treat Vs Wait trend trend trend t(45)= , p=.066 t(45)= ; p=.065 t(45)= , p=.035 t(45) = ; p=.012 t(44)= ; p=.077 t(45)= ; p=.001 t(45)=-2.353, p=0.023 p < 0.05 Results: Treat vs Waitlist Clinical Domains PANSS + PANSS - PANSS gen Calgary DRS CPZ equi SOFAS Self Esteem Treat vs Waitlist t(42)= 1.098; p=.278 t(41)=.218; p=.829 t(42)=.536; p=.595 t(44)= 1.018; p=.314 t(41)=.480; p=.633 t(42)= ; p=.004 t(41)= -.838; p=.407
13 Hypothesis 2: That improvement in cognition would persist over a 15 week follow-up Results: Follow-up Domain Attention Working Memory Delayed Verbal Recall Delay Visual Recall Cognitive Flex. Executive Fx Processing Speed Followup vs End of Treatment n.s t(32)=.432; p=.669 t(37)= -.845; p=.404 t(37)=.927; p=.360 t(36)= -.912; p=.368 t(36)= ; p=.008 t(37)= -.832; p=.411 t(37)= -.764; p=.450
14 Results: Follow-up Clinical Domains PANSS + PANSS - PANSS gen Calgary DRS CPZ equi SOFAS Self Esteem Followup vs End of Treatment t(34)=.704; p=.486 t(33)=.261; p=.796 t(33)= 1.111; p=.275 t(34)= -.509; p=.614 t(26)= ; p=.186 t(33)= -.022; p=.983 t(25)= -.866; p=.395 Occupational Outcome Occupational Outcome 35 After Treat Follow-up per cent in-pt Comm. SB Unemp. S.W. P/T F/T Wilcoxon Z= ; p = 0.003
15 Hypothesis 3: That recent onset schizophrenia would have greater improvement than chronic schizophrenia Demographics Age Illness (yrs) CPZ equi Recent Onset Sz Mean SE Chronic Sz Mean SE Calgary DRS PANSS PANSS PANSS gen SOFAS Rosenberg SES
16 Results: Recent Onset vs Chronic Schizophrenia Domain RO vs CSz Treat vs Base Interaction Attention p < p = Working Memory p = p = Delayed Verbal Recall p = Delay Visual Recall p = p < p = Cognitive Flex. p = p < Executive Fx p = p < Processing Speed p = p = Change in function SOFAS score Baseline Post-treat 10 0 Recent Onset Chronic Sz Trend p = 0.07
17 Conclusions Cognitive remediation improves performance of people with schizophrenia over a wide range of cognitive domains These effects persist at least over a three month period They are accompanied by indications of some functional improvement Slight advantage for recent onset schizophrenia in treatment effect Continuing research Is there a threshold of improvement before effects can generalise to social functioning? Are there specific cognitive domains that need to be targeted? Is improvement restricted to certain social domains? What is the dose of treatment required? Do you need booster sessions to keep the effect? How long does the effect last?
18 Contributors to the Research Cognitive Remediation Team Daniella Siciliano Antoinette Redoblado- Hodge Pam Rogers David Cairns Clinicians at the treatment centres All our patients Centres Cumberland Hospital Macquarie Hospital PEIRS Granville Rehabilitation EPIP / Hornsby Brookvale Early Psychosis Team Chatswood MHT Wahroonga MHT Windsor MHT
A Randomized Controlled Trial of Cognitive Remediation in Schizophrenia
Schizophrenia Bulletin vol. 36 no. 2 pp. 419 427, 2010 doi:10.1093/schbul/sbn102 Advance Access publication on August 20, 2008 A Randomized Controlled Trial of Cognitive Remediation in Schizophrenia Marie
More informationMethod. NeuRA Schizophrenia and bipolar disorder April 2016
Introduction Schizophrenia is characterised by positive, negative and disorganised symptoms. Positive symptoms refer to experiences additional to what would be considered normal experience, such as hallucinations
More informationService Related Project. Kimberley Keegan
AN EVALUATION OF ADDENBROOKE S COGNITIVE EXAMINATION III (ACE-III) SCORES, NEUROPSYCHOLOGICAL ASSESSMENT SCORES, AND DIAGNOSIS OUTCOME WITHIN A MEMORY SERVICE. Service Related Project Kimberley Keegan
More informationEarly Psychosis Services: Philadelphia PEACE Program
Early Psychosis Services: Philadelphia PEACE Program Irene Hurford, M.D. Clinical Director, PEACE Program, Horizon House Assistant Professor, Department of Psychiatry, University of Pennsylvania 1 John
More informationCognitive enhancement therapy in schizophrenia. Matcheri S Keshavan MD
Cognitive enhancement therapy in schizophrenia Matcheri S Keshavan MD Harvard Medical School, Massachusetts Mental Health Center and Beth Israel Deaconess Medical Center NIMH MH 60902, 92440 and 105596;
More informationSupplementary Online Content
Supplementary Online Content Sun LS, Li G, Miller TLK, et al. Association between a single general anesthesia exposure before age 36 months and neurocognitive outcomes in later childhood. JAMA. doi:10.1001/jama.2016.6967
More informationIdentifying Youth at Clinical High Risk for Psychosis
Identifying Youth at Clinical High Risk for Psychosis Jean Addington PhD University of Calgary Department of Psychiatry 1 Identifying Youth at Clinical High Risk for Psychosis Part 1: What do we know about
More informationThe Neuropsychology of
The Neuropsychology of Stroke Tammy Kordes, Ph.D. Northshore Neurosciences Outline What is the Role of Neuropsychology Purpose of Neuropsychological Assessments Common Neuropsychological Disorders Assessment
More informationCRITICALLY APPRAISED PAPER (CAP)
CRITICALLY APPRAISED PAPER (CAP) Couillet, J., Soury, S., Lebornec, G., Asloun, S., Joseph, P., Mazaux, J., & Azouvi, P. (2010). Rehabilitation of divided attention after severe traumatic brain injury:
More informationSupplementary Online Content
Supplementary Online Content Devenney E, Bartley L, Hoon C, et al. Progression in behavioral variant frontotemporal dementia: a longitudinal study. JAMA Neurol. Published online October 26, 2015. doi:10.1001/jamaneurol.2015.2061.
More informationNeurocognition and Schizophrenia
Neurocognition and Schizophrenia Presenter Dr Swapna MBBS DPM MD PG III Outline Concepts and Development of neurocognition Domains of neurocognition in schizophrenia Specific emphasis on intelligence pertinent
More informationEarly intervention in Bipolar Disorder
Early intervention in Bipolar Disorder Lakshmi N. Yatham MBBS, FRCPC, MRCPsych Professor of Psychiatry, University of British Columbia, Vancouver, Canada Early Intervention in Bipolar Disorder High Risk
More information6th International Conference on Early Psychosis
OR015. Story production in first episode psychosis: the role of verbal learning memory and verbal fluency HJ Stain,1 S Hodne,2 I Joa,2 JO Johannesen,2 BR Rund,3 W ten Velden Hegelstad,2 TK Larsen2 1Centre
More informationProcess of a neuropsychological assessment
Test selection Process of a neuropsychological assessment Gather information Review of information provided by referrer and if possible review of medical records Interview with client and his/her relative
More informationCognitive Remediation Therapy (CRT)
Cognitive Remediation Therapy (CRT) Experiences of implementation in inpatient rehabilitation services Dr Ian-Mark Kevan (Consultant Clinical Psychologist) BPS PCMHF Event 24 th March 2017 - Stirling Plan
More informationCarmen Inoa Vazquez, Ph.D., ABPP Clinical Professor NYU School of Medicine Lead Litigation Conference Philadelphia May 19, 2009 Presentation
Carmen Inoa Vazquez, Ph.D., ABPP Clinical Professor NYU School of Medicine Lead Litigation Conference Philadelphia May 19, 2009 Presentation Neuropsychological Tests Battery The following List represents
More informationEthical Research Comittee
How should we take care of Schizophrenia today? Dr Laurence LACOSTE Saint Louis Hospital, Paris, France Ethical Research Comittee 1 Introduction: Schizophrenia and Psychiatry In psychiatric hospitals,
More informationMaree Reser Doctorate of Psychology (clinical) candidate Swinburne University of Technology
Maree Reser Doctorate of Psychology (clinical) candidate Swinburne University of Technology Currently recruiting people with a diagnosis of schizophrenia or schizoaffective disorder to participate in a
More informationOffice Practice Coding Assistance - Overview
Office Practice Coding Assistance - Overview Three office coding assistance resources are provided in the STABLE Resource Toolkit. Depression & Bipolar Coding Reference: n Provides ICD9CM and DSM-IV-TR
More informationNeuropsychological Evaluation of
Neuropsychological Evaluation of Alzheimer s Disease Joanne M. Hamilton, Ph.D. Shiley-Marcos Alzheimer s Disease Research Center Department of Neurosciences University of California, San Diego Establish
More informationSOCIABLE DELIVERABLE D7.2a Interim Assessment of the SOCIABLE Platform and Services
SOCIABLE ICT-PSP No. 238891 SOCIABLE DELIVERABLE D7.2a Interim Assessment of the SOCIABLE Platform and Services Project Acronym SOCIABLE Grant Agreement No. 238891 Project Title Motivating platform for
More informationSOCIABLE - NEXT GENERATION COGNITIVE TRAINING USING MULTI-TOUCH SURFACE COMPUTERS
SOCIABLE - NEXT GENERATION COGNITIVE TRAINING USING MULTI-TOUCH SURFACE COMPUTERS Dr Paraskevi Sakka Neurologist - Psychiatrist Athens Association of Alzheimer s Disease and Related Disorders Neurodegenerative
More informationCHAPTER 9.1. Summary
CHAPTER 9.1 Summary 174 TRAUMA-FOCUSED TREATMENT IN PSYCHOSIS Treating PTSD in psychosis The main objective of this thesis was to test the effectiveness and safety of evidence-based trauma-focused treatments
More informationCRITICALLY APPRAISED PAPER (CAP)
CRITICALLY APPRAISED PAPER (CAP) Godefroy, O., Fickl, A., Roussel, M., Auribault, C., Bugnicourt, J. M., Lamy, C., Petitnicolas, G. (2011). Is the Montreal cognitive assessment superior to the mini-mental
More informationLambros Messinis PhD. Neuropsychology Section, Department of Neurology, University of Patras Medical School
Lambros Messinis PhD Neuropsychology Section, Department of Neurology, University of Patras Medical School Type 2 Diabetes Mellitus is a modern day epidemic Age is a significant predictor of diabetes Males
More informationOccupational Therapy for First Episode Psychosis
2018 International OT Conference Occupational Therapy for First Episode Psychosis Ms. Yeung Sau Fong, Odelia Occupational Therapy Department Kwai Chung Hospital HKSAR Early intervention Stage specific
More informationPlenary Session 2 Psychometric Assessment. Ralph H B Benedict, PhD, ABPP-CN Professor of Neurology and Psychiatry SUNY Buffalo
Plenary Session 2 Psychometric Assessment Ralph H B Benedict, PhD, ABPP-CN Professor of Neurology and Psychiatry SUNY Buffalo Reliability Validity Group Discrimination, Sensitivity Validity Association
More informationThe Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery
Schizophrenia Research 68 (2004) 283 297 www.elsevier.com/locate/schres The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery
More informationTable 1: Summary of measures of cognitive fatigability operationalised in existing research.
Table 1: Summary of measures of cognitive fatigability operationalised in existing research. Candidate Mmeasures Studies Procedure Self-reported fatigue measure Key Findings The auditory As and auditory
More informationImproving the Methodology for Assessing Mild Cognitive Impairment Across the Lifespan
Improving the Methodology for Assessing Mild Cognitive Impairment Across the Lifespan Grant L. Iverson, Ph.D, Professor Department of Physical Medicine and Rehabilitation Harvard Medical School & Red Sox
More informationMeta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives
SUPPLEMENTARY MATERIAL Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives B. Arts 1 *, N. Jabben 1, L. Krabbendam 1 and J. van Os 1,2 1 Department of Psychiatry
More informationKorean-VCI Harmonization Standardization- Neuropsychology Protocol (K-VCIHS-NP)
Korean-VCI Harmonization Standardization- Neuropsychology Protocol (K-VCIHS-NP) Yeonwook Kang, Ph.D. Department of Psychology, Hallym University Department of Neurology, Hallym University Sacred Heart
More informationCognitive impairment in first-episode mania: a systematic review of the evidence in the acute and remission phases of the illness
Daglas et al. International Journal of Bipolar Disorders (2015) 3:9 DOI 10.1186/s40345-015-0024-2 REVIEW Open Access Cognitive impairment in first-episode mania: a systematic review of the evidence in
More informationThe outlook for schizophrenia is better than we think but is being sabotaged by Assembly-line Psychiatry
The outlook for schizophrenia is better than we think but is being sabotaged by Assembly-line Psychiatry Robin M Murray Department of Psychosis Studies Institute of Psychiatry King s College London robin.murray@kcl.ac.uk
More informationCognitive Screening in Risk Assessment. Geoffrey Tremont, Ph.D. Rhode Island Hospital & Alpert Medical School of Brown University.
Cognitive Screening in Risk Assessment Geoffrey Tremont, Ph.D. Rhode Island Hospital & Alpert Medical School of Brown University Outline of Talk Definition of Dementia and MCI Incidence and Prevalence
More informationNeuropsychological Testing (NPT)
Neuropsychological Testing (NPT) POLICY Psychological testing (96101-03) refers to a series of tests used to evaluate and treat an individual with emotional, psychiatric, neuropsychiatric, personality
More informationAMNESTIC MINIMAL COGNITIVE IMPAIRMENT: BEYOND MEMORY
AMNESTIC MINIMAL COGNITIVE IMPAIRMENT: BEYOND MEMORY R. Balachandar 1,, R. Tripati 2, S. Bharath 1, S. Sadanand 1, P. T. Sivakumar 1, K. Kumar 2, S. Loganathan 1, S. R. Chandra 3, M. Vargese 1 1 Dept.
More informationThe implementation of cognitive remediation interventions in Campania
Original article The implementation of cognitive remediation interventions in Campania JOURNAL OF PSYCHOPATHOLOGY 2018;24:98-103 D. Palumbo*, S. Patriarca*, A. Mucci, M. De Angelis, I. Di Crosta, G. Piegari,
More informationTests/subtests that may capture this skill a,b. How it might look in school or in the home c Response inhibition
Executive Skill How the skill may appear in testing situations Tests/subtests that may capture this skill a,b Where it might be seen on a behavior rating scale b How it might look in school or in the home
More informationCRITICALLY APPRAISED PAPER (CAP)
CRITICALLY APPRAISED PAPER (CAP) Twamley, E. W., Jak, A. J., Delis, D. C., Bondi, M. W., & Lohr, J. B. (2014). Cognitive Symptom Management and Rehabilitation Therapy (CogSMART) for Veterans with traumatic
More informationAdvisory Boards -- Dainippon Sumito Pharma; Takeda and Lundbeck. Off-label data included for Mirapex (pramipexole)
Disclosures Advisory Boards -- Dainippon Sumito Pharma; Takeda and Lundbeck Off-label data included for Mirapex (pramipexole) Funding from NIMH; Stanley Medical Research Institute; NARSAD A Brief History
More informationEarly Stages of Psychosis. Learning Objectives
Early Stages of Psychosis Stephan Heckers, MD MSc Department of Psychiatry and Behavioral Sciences Vanderbilt University Learning Objectives Summarize the five domains of psychosis Describe how psychotic
More informationMeasurement and Classification of Neurocognitive Disability in HIV/AIDS Robert K. Heaton Ph.D University of California San Diego Ancient History
Measurement and Classification of Neurocognitive Disability in HIV/AIDS Robert K. Heaton Ph.D University of California San Diego Ancient History Group Means for NP and MMPI Variables N=381 Consecutive
More informationCHAPTER 5 NEUROPSYCHOLOGICAL PROFILE OF ALZHEIMER S DISEASE
CHAPTER 5 NEUROPSYCHOLOGICAL PROFILE OF ALZHEIMER S DISEASE 5.1 GENERAL BACKGROUND Neuropsychological assessment plays a crucial role in the assessment of cognitive decline in older age. In India, there
More informationDiagnosed with Psychotic
Cognitive Symptom Trajectories among Forensic Inpatients Diagnosed with Psychotic Disorders CSU Student Research Competition May 4 th -5 th, 2018 By: Jennifer Hatch Mentor: Danielle Burchett, PhD California
More informationExploration of a weighed cognitive composite score for measuring decline in amnestic MCI
Exploration of a weighed cognitive composite score for measuring decline in amnestic MCI Sarah Monsell NACC biostatistician smonsell@uw.edu October 6, 2012 Background Neuropsychological batteries used
More informationSchizophrenia and Other Psychotic Disorders
Schizophrenia and Other Psychotic Disorders Chapter 14 This multimedia product and its contents are protected under copyright law. The following are prohibited by law: any public performance or display,
More informationNicotinic Agonists for Cognitive Deficits in Schizophrenia: A Case Report
Nicotinic Agonists for Cognitive Deficits in Schizophrenia: A Case Report Annette Kennedy, PsyD Seattle Inst of Biomedical & Clinical Research, Mental Illness Research Education & Clinical Center (MIRECC)
More informationEARLY ONSET FRONTOTERMPORAL DEMENTIA AND ALZHEIMERS DISEASE: DIAGNOSIS, TREATMENT AND CARE
EARLY ONSET FRONTOTERMPORAL DEMENTIA AND ALZHEIMERS DISEASE: DIAGNOSIS, TREATMENT AND CARE John Rudge, BA Hons This thesis is presented as partial requirement for the degree of Doctor of Psychology at
More informationThe neurocognitive functioning in bipolar disorder: a systematic review of data
DOI 10.1186/s12991-015-0081-z Annals of General Psychiatry PRIMARY RESEARCH Open Access The neurocognitive functioning in bipolar disorder: a systematic review of data Eirini Tsitsipa 1 and Konstantinos
More informationMental Health Disorders Civil Commitment UNC School of Government
Mental Health Disorders 2017 Civil Commitment UNC School of Government Edward Poa, MD, FAPA Chief of Inpatient Services, The Menninger Clinic Associate Professor, Baylor College of Medicine NC statutes
More informationCognitive Remediation Intervention for people with Schizophrenia and Schizoaffective disorder in the Cavan Rehabilitation Service
Royal College of Psychiatrists The Douglas Bennett Prize Cognitive Remediation Intervention for people with Schizophrenia and Schizoaffective disorder in the Cavan Rehabilitation Service Nnamdi Nkire,
More informationAPPENDIX A TASK DEVELOPMENT AND NORMATIVE DATA
APPENDIX A TASK DEVELOPMENT AND NORMATIVE DATA The normative sample included 641 HIV-1 seronegative gay men drawn from the Multicenter AIDS Cohort Study (MACS). Subjects received a test battery consisting
More informationPrevalence of cognitive impairment in major depression and bipolar disorder
Received: 7 September 2017 Revised: 5 November 2017 Accepted: 15 December 2017 DOI: 10.1111/bdi.12602 ORIGINAL ARTICLE Prevalence of cognitive impairment in major depression and bipolar disorder Katie
More informationThe British Approach to Understanding and Treating Psychosis
The British Approach to Understanding and Treating Psychosis Robin M Murray Professor of Psychiatric Research Department of Psychosis Studies Institute of Psychiatry robin.murray@kcl.ac.uk Which boy will
More informationNeurocognitive and psychosocial outcomes of obstructive sleep apnoea in Hong Kong Chinese
HEALTH AND HEALTH SERVICES RESEARCH FUND Neurocognitive and psychosocial outcomes of obstructive sleep apnoea in Hong Kong Chinese EYY Lau *, MSM Ip, TMC Lee K e y M e s s a g e s 1. Patients with obstructive
More informationCALYPSOS BRIEF FINAL REPORT ON THE INTELLECTUAL OUTPUTS OF THE PROJECT
CALYPSOS BRIEF FINAL REPORT ON THE INTELLECTUAL OUTPUTS OF THE PROJECT The "Calypsos" Project, supporting social inclusion, specific needs and the improvement of basic skills for prisoners in Europe (2016-1-ES01-KA204-025656),
More informationW E N D Y H A R T I N G E R
EDUCATION W E N D Y H A R T I N G E R 9 4 5 1 1 T H A V E N U E, S U I T E B, L O N G V I E W, W A 9 8 6 3 2 P H O N E ( 3 6 0 ) 4 1 4-8 6 0 0 E - M A I L W H A R T I N G E R @ N W P S Y C H. C O M Anticipated
More informationCRITICALLY APPRAISED PAPER
CRITICALLY APPRAISED PAPER FOCUSED QUESTION For individuals with memory and learning impairments due to traumatic brain injury, does use of the self-generation effect (items self-generated by the subject)
More informationM P---- Ph.D. Clinical Psychologist / Neuropsychologist
M------- P---- Ph.D. Clinical Psychologist / Neuropsychologist NEUROPSYCHOLOGICAL EVALUATION Name: Date of Birth: Date of Evaluation: 05-28-2015 Tests Administered: Wechsler Adult Intelligence Scale Fourth
More informationREHABILITATION FOR SURVIVORS OF CRITICAL ILLNESS FOLLOWING HOSPITAL DISCHARGE
A UK Survey of Rehabilitation Following Critical Illness: Implementation of NICE Clinical Guidance 83 (CG83) Following Hospital Discharge DATA SUPPLEMENT - REHABILITATION SURVEY REHABILITATION FOR SURVIVORS
More informationRESEARCH OBJECTIVE(S) List study objectives.
CRITICALLY APPRAISED PAPER (CAP) Zickefoose, S., Hux, K., Brown, J., & Wulf, K. (2013). Let the games begin: A preliminary study using Attention Process Training-3 and Lumosity brain games to remediate
More informationThe Tides of Change: Implementing Early Onset Psychosis Services with a National Thought Leader
The Tides of Change: Implementing Early Onset Psychosis Services with a National Thought Leader John M. Kane, M.D. Professor and Chairman Department of Psychiatry Hofstra North Shore-LIJ School of Medicine
More informationFaculty. Delivering and Measuring the Outcomes of Cognitive Remediation across Clinical Settings. Evidence Base for Cognitive Remediation Therapy
Faculty Delivering and Measuring the Outcomes of Cognitive Remediation across Clinical Settings Philip D. Harvey, PhD Leonard M. Miller Professor University of Miami Miller School of Medicine Miami, Florida
More informationA systematic review on improving cognition in schizophrenia: which is the more commonly used type of training, practice or strategy learning?
Paquin et al. BMC Psychiatry 2014, 14:139 RESEARCH ARTICLE Open Access A systematic review on improving cognition in schizophrenia: which is the more commonly used type of training, practice or strategy
More informationUpdate on First Psychotic Episodes in Childhood and Adolescence. Cheryl Corcoran, MD Assistant Professor of Psychiatry Columbia University
Update on First Psychotic Episodes in Childhood and Adolescence Cheryl Corcoran, MD Assistant Professor of Psychiatry Columbia University Childhood-Onset Psychosis 8% of psychiatrically referred youth
More informationMark R Peltan, Ph.D Director - Clinical Psychologist. Behavioral Services Access Center
Mark R Peltan, Ph.D Director - Clinical Psychologist Facts and figures Behavioral Services Access Center 641-428-6070 30-bed Inpatient Psychiatric Unit 641-428-7737 Manager Joellen Steil, MSN --14 psychiatric
More informationSeveral studies have demonstrated. Cognitive and Symptom Predictors of Work Outcomes for Clients With Schizophrenia in Supported Employment
Cognitive and Symptom Predictors of Work Outcomes for Clients With Schizophrenia in Supported Employment Susan R. McGurk, Ph.D. Kim T. Mueser, Ph.D. Phil D. Harvey, Ph.D. Richard LaPuglia, M.A. Joan Marder,
More informationMethod. NeuRA Cholinesterase inhibitors August 2016
Introduction A supplementary, or adjunctive, treatment is administered in conjunction with a patient s ongoing antipsychotic therapy. (ChEI), or anticholinesterase, have been proposed as an additional
More informationNeuropsychological Performance in Cannabis Users and Non-Users Following Motivation Manipulation
University at Albany, State University of New York Scholars Archive Psychology Honors College 5-2010 Neuropsychological Performance in Cannabis Users and Non-Users Following Motivation Manipulation Michelle
More informationConcise Reference Cognitive Dysfunction in Schizophrenia Richard Keefe, Martin Lambert, Dieter Naber
Concise Reference Cognitive Dysfunction in Schizophrenia Richard Keefe, Martin Lambert, Dieter Naber Concise Reference Cognitive Dysfunction in Schizophrenia Extracted from Current Schizophrenia, Third
More informationAffective Disorders most often should be viewed in conjunction with other physical and mental impairments.
THESE ARE THE FORMS I USE THIS IS NOT LEGAL ADVICE AND INTENDED TO SUPPLEMENT YOUR PARTICULAR FACTUAL SITUATION ONLY It is crucial you educate yourself on the Social Security Regulations that define and
More informationNeuropsychological Testing in Occupational Medicine
Neuropsychological Testing in Occupational Medicine When is a referral appropriate and what will neuropsychological testing offer? Nancy Fiedler, Ph.D. Rutgers, The State University of New Jersey Objectives
More informationDate of Onset is defined as the first day the claimant meets the definition of disability as defined in the Act and regulations.
THESE ARE THE FORMS I USE THIS IS NOT LEGAL ADVICE AND INTENDED TO SUPPLEMENT YOUR PARTICULAR FACTUAL SITUATION ONLY It is crucial you educate yourself on the Social Security Regulations that define and
More informationRESEARCH UPDATES: Improving Functioning In Schizophrenia?
RESEARCH UPDATES: Improving Functioning In Schizophrenia? Stephen R. Marder, MD Professor and Director, Section on Psychosis Semel Institute for Neuroscience and Human Behavior at UCLA Director, Mental
More informationCluster 1 Common Mental Health Problems (mild)
Cluster 1 Common Mental Health Problems (mild) You have recently sought help for the first time. You have experienced depression and/or anxiety. This may cause distraction or minor disruption to you as
More informationMental Health Nursing: Suicidal Behavior. By Mary B. Knutson, RN, MS, FCP
Mental Health Nursing: Suicidal Behavior By Mary B. Knutson, RN, MS, FCP Self-Protective Responses Protection and survival are fundamental needs of all living things Life is characterized by risk Individuals
More informationImplications of Neuropsychological Functioning on Treatment
Implications of Neuropsychological Functioning on Treatment Paul Connor, Ph.D. University of Washington Private Practice Des Moines, WA USA paul@connornp.com www.connorneuropsychology.com Let s Talk Adults
More informationDisease Modification in Schizophrenia: Overview of the Issues. ISCTM February 18 th 2014 Ravi Anand, MD Switzerland
Disease Modification in Schizophrenia: Overview of the Issues ISCTM February 18 th 2014 Ravi Anand, MD Switzerland Need for a New Treatment Paradigm in Schizophrenia Sixty years after approval for the
More informationNeuropsychological Correlates of Performance Based Functional Status in Elder Adult Protective Services Referrals for Capacity Assessments
Neuropsychological Correlates of Performance Based Functional Status in Elder Adult Protective Services Referrals for Capacity Assessments Jason E. Schillerstrom, MD schillerstr@uthscsa.edu Schillerstrom
More informationRelationship Between Duration of Untreated Psychosis and Outcome in First-Episode Schizophrenia: A Critical Review and Meta-Analysis
Reviews and Overviews Relationship Between Duration of Untreated Psychosis and Outcome in First-Episode Schizophrenia: A Critical Review and Meta-Analysis Diana O. Perkins, M.D., M.P.H. Hongbin Gu, Ph.D.
More informationCan aspirin slow cognitive decline and the onset of dementia? The ASPREE study. Mark Nelson on behalf of ASPREE Investigators
Can aspirin slow cognitive decline and the onset of dementia? The ASPREE study. Mark Nelson on behalf of ASPREE Investigators ASPREE Randomized, double-blind, placebo-controlled trial for extending healthy
More informationEarly Detection of Childhood Schizophrenia: What This Might Mean for Our Work
Early Detection of Childhood Schizophrenia: What This Might Mean for Our Work April 17, 2013 Michel Maziade, M.D., FRCPC, C.Q. Canada Research Chair in the Genetics of Neuropsychiatric Disorders, Full
More informationValidation of ipad based treatment 1
1 Introduction About 795,000 Americans each year suffer a new or recurrent stroke (NIDCD.gov). Also, about 1.7 million individuals suffer from traumatic brain injury each year (CDC.gov). Individuals with
More informationNEUROPSYCHOMETRIC TESTS
NEUROPSYCHOMETRIC TESTS CAMCOG It is the Cognitive section of Cambridge Examination for Mental Disorders of the Elderly (CAMDEX) The measure assesses orientation, language, memory, praxis, attention, abstract
More informationDate of Onset is defined as the first day the claimant meets the definition of disability as defined in the Act and regulations.
THESE ARE THE FORMS I USE THIS IS NOT LEGAL ADVICE AND INTENDED TO SUPPLEMENT YOUR PARTICULAR FACTUAL SITUATION ONLY It is crucial you educate yourself on the Social Security Regulations that define and
More informationAn Introduction to the Pharmacogenetics of Cognitive Improvement in Schizophrenia
An Introduction to the Pharmacogenetics of Cognitive Improvement in Schizophrenia 14 th Edmonton Schizophrenia Conference Neil D. Woodward MA Ph.D. Candidate Vanderbilt University & Clinical Neuropsychology
More informationPsychotic Disorders. Schizophrenia. Age Distribution of Onset 2/24/2009. Schizophrenia. Hallmark trait is psychosis
Psychotic Disorders Schizophrenia Schizophrenia Affects people from all walks of life Is about as prevalent as epilepsy Usually begins in late adolescence or early adulthood Hallmark trait is psychosis
More informationCondensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia
Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia I. Key Points a. Schizophrenia is a chronic illness affecting all aspects of person s life i. Treatment Planning Goals 1.
More informationNeuroTracker Published Studies & Research
NeuroTracker Published Studies & Research Evidence of Relevance in Measurement, Learning and Transfer for Learning and Learning Related Conditions NeuroTracker evolved out of a pure science approach through
More informationComparing MCI Patients to Healthy Controls using Three ERP Paradigms
Comparing MCI Patients to Healthy Controls using Three ERP Paradigms Electrophysiology PIA AAIC 2015 Washington, DC Frank Knoefel, Rocío López Zunini, Vanessa Taler, Michael Breau, Lisa Sweet, Courtney
More information1. Introduction. Correspondence should be addressed to Amélie M. Achim;
Hindawi Schizophrenia Research and Treatment Volume 2017, Article ID 7203871, 15 pages https://doi.org/10.1155/2017/7203871 Research Article Improving Theory of Mind in Schizophrenia by Targeting Cognition
More informationCRITICALLY APPRAISED PAPER
CRITICALLY APPRAISED PAPER Kesler, S., Hadi Hosseini, S. M., Heckler, C., Janelsins, M., Palesh, O., Mustian, K., & Morrow, G. (2013). Cognitive training for improving executive function in chemotherapy-treated
More informationEffects of Comorbid Disease on Pre-treatment Neurobehavioral Functioning. Sunita K. Patel, PhD Assistant Professor. City of Hope Medical Center
Effects of Comorbid Disease on Pre-treatment Neurobehavioral Functioning. Sunita K. Patel, PhD Assistant Professor City of Hope Medical Center Duarte, California. Pre-Chemotherapy e e apycognitive Functioning
More informationRecovery Oriented Prescribing Why take any medication?
Recovery Oriented Prescribing Why take any medication? June 15, 2012 University of Wisconsin Department of Psychiatry Medical Director, Journey Mental Health Center of Dane County Consultant, Wisconsin
More informationDisorders of working memory: Causes and remediation
Disorders of working memory: Causes and remediation Dr Joni Holmes MRC Cognition and Brain Sciences Unit Pearson Online Working Memory Week, 18 th November 2013 WM: Key features Capacity to hold material
More informationNeuRA Decision making April 2016
Introduction requires an individual to use their knowledge and experience of a context in order to choose a course of action 1. A person s ability to autonomously make decisions is referred to as their
More informationCRITICALLY APPRAISED PAPER (CAP)
CRITICALLY APPRAISED PAPER (CAP) Söderlund, G. B. W., Björk, C., & Gustafsson, P. (2016). Comparing auditory noise treatment with stimulant medication on cognitive task performance in children with attention
More information